Search
Co-Altria/Co-Altria Ped

Co-Altria/Co-Altria Ped

Manufacturer:

Ajanta Pharma Phil

Distributor:

Ajanta Pharma Phil
Concise Prescribing Info
Contents
Co-Altria tab Montelukast Na 10 mg, levocetirizine HCl 5 mg. Co-Altria Ped chewable tab 5 mg/2.5 mg Montelukast Na 5 mg, levocetirizine diHCl 2.5 mg. 5mg/5 mg Montelukast Na 5 mg, levocetirizine diHCl 5 mg
Indications/Uses
Relief of symptoms associated w/ seasonal & perennial allergic rhinitis.
Click to view Co-Altria/Co-Altria Ped detailed prescribing information
Dosage/Direction for Use
Co-Altria tab Adult & childn ≥15 yr 1 tab once daily. Co-Altria Ped chewable tab Childn 6-14 yr 1 tab once daily.
Click to view Co-Altria/Co-Altria Ped detailed prescribing information
Administration
May be taken with or without food.
Contraindications
Hypersensitivity. Severe renal (CrCl <10 mL/min) or hepatic impairment. Pregnancy & lactation. Childn 6-11 yr w/ renal impairment.
Click to view Co-Altria/Co-Altria Ped detailed prescribing information
Special Precautions
Mild to moderate renal impairment. May impair ability to drive or operate machinery. Not recommended to patients w/ severe hepatic impairment. Co-Altria Ped Levocetirizine diHCl: May experience somnolence, fatigue & asthenia affecting ability to drive or operate machinery. Not recommended to infants & toddlers <2 yr.
Click to view Co-Altria/Co-Altria Ped detailed prescribing information
Adverse Reactions
Levocetirizine: Somnolence, dry mouth. Montelukast: Asthenia/fatigue, fever, abdominal pain, trauma; dyspepsia, infectious gastroenteritis, dental pain; dizziness, headache; nasal congestion, cough, flu; rash; increased ALT & AST, pyuria.
Click to view Co-Altria/Co-Altria Ped detailed prescribing information
Drug Interactions
Levocetirizine: Decreased clearance w/ theophylline. Increased plasma AUC, t½ & decreased clearance w/ ritonavir. Montelukast: Decreased plasma conc w/ phenobarb. Co-administration w/ CYP3A4 inducers eg, phenytoin, phenobarb & rifampicin.
Click to view Co-Altria/Co-Altria Ped detailed prescribing information
Storage
View Co-Altria/Co-Altria Ped storage conditions for details to ensure optimal shelf-life.
Description
View Co-Altria/Co-Altria Ped description for details of the chemical structure and excipients (inactive components).
Action
View Co-Altria/Co-Altria Ped mechanism of action for pharmacodynamics and pharmacokinetics details.
ATC Classification
R03DC53 - montelukast, combinations ; Belongs to the class of leukotriene receptor antagonists. Used in the systemic treatment of obstructive airway diseases.
Presentation/Packing
Form
Co-Altria 10 mg/5 mg tab
Packing/Price
30's
Form
Co-Altria Ped 5 mg/5 mg chewable tab
Packing/Price
30's
Form
Co-Altria Ped 5 mg/2.5 mg chewable tab
Packing/Price
30's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in